Hem › Neuroendokrina tumörer › Pennsylvania
Kliniska studier för Neuroendokrina tumörer i Pennsylvania
12 studier för Neuroendokrina tumörer söker deltagare vid platser i Pennsylvania.
Städer i Pennsylvania
Officiell studietext (engelska)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06943755Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
RekryterarFas 1
24 Months – 18 Years · Alla kön · Uppdaterad 25 sep. 2026 · NCT06441331Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
- Hospital of the University of Pennsylvania, Philadelphia
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT07087054Project: Every Child for Younger Patients With Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- och 4 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Philadelphia
- Crinetics Study Site, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT07129252Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- Fox Chase Cancer Center, Philadelphia
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 juli 2026 · NCT05263050CapTemY90 for Grade 2/3 NET Liver Metastases
- University of Pennsylvania, Philadelphia
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 juni 2026 · NCT04339036Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
- University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 20 till 99 · Alla kön · Uppdaterad 20 apr. 2026 · NCT02174549Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Research Facility, Pittsburgh
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 mars 2026 · NCT05477576A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
- University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 18 till 85 · Alla kön · Uppdaterad 29 jan. 2026 · NCT06055439Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Penn State Hershey Medical Center, Hershey
- Albert Einstein Healthcare Network, Philadelphia
RekryterarFas 4
Ålder 18 till 64 · Alla kön · Uppdaterad 22 jan. 2026 · NCT04373564SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.